Easy Scalability, Lower Risk
Targeted Polysaccharide Nanoparticles
We possess proprietary, widely patented technology for the production and integration of polysaccharide nanoparticles.
Our polysaccharide nanoparticles utilize two targeting mechanisms:
- Drug Release Based on Intracellular pH Level – Nanoparticles enter the cell through endosomes. As a result of the low pH in the endosome, the bond breaks and the active substance is released.
- EPR Effect (Enhanced Permeability and Retention) – The rapid growth of tumor cells requires increased blood supply, resulting in greater permeability of blood vessels. Nanoparticles sized 100-200nm have a higher chance of reaching cancer cells.
Vehicle for Nanoformulation of Already Approved Drugs with Proven Effectiveness
This allows for improving their efficiency and safety.
FLEXIBILITY
Enables quick initiation of new projects, leading to the creation of derivative patents based on the core technology.
LIMITED RISK
Uses known and well-researched active substances with established therapeutic profiles and side effects, reducing developmental risks.
REPEATABILITY OF THE PROJECT
The polysaccharide nanoparticle technology accelerates project execution by leveraging the effects of previous studies.
STRONG SCIENTIFIC FOUNDATION
Research conducted in international centers forms the foundation for derivative projects.
